102 related articles for article (PubMed ID: 20865660)
1. Expression of mitotic kinases phospho-aurora A and aurora B correlates with clinical and pathological parameters in bladder neoplasms.
Bufo P; Sanguedolce F; Tortorella S; Cormio L; Carrieri G; Pannone G
Histol Histopathol; 2010 Nov; 25(11):1371-7. PubMed ID: 20865660
[TBL] [Abstract][Full Text] [Related]
2. Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.
Pannone G; Hindi SA; Santoro A; Sanguedolce F; Rubini C; Cincione RI; De Maria S; Tortorella S; Rocchetti R; Cagiano S; Pedicillo C; Serpico R; Lo Muzio L; Bufo P
Int J Immunopathol Pharmacol; 2011; 24(1):79-88. PubMed ID: 21496390
[TBL] [Abstract][Full Text] [Related]
3. Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancer.
Compérat E; Roupret M; Conort P; Chartier-Kastler E; Bitker MO; Richard F; Capron F; Haertig A; Cussenot O; Camparo P
Urol Int; 2009; 82(3):312-7. PubMed ID: 19440020
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Aurora-A expression in human bladder cancer.
Lei Y; Yan S; Ming-De L; Na L; Rui-Fa H
Acta Histochem; 2011 Sep; 113(5):514-8. PubMed ID: 20598352
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms.
Compérat E; Camparo P; Haus R; Chartier-Kastler E; Radenen B; Richard F; Capron F; Paradis V
Virchows Arch; 2007 Apr; 450(4):419-24. PubMed ID: 17333265
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinase B is an independent protective factor in superficial bladder tumours with a dysfunctional G1 checkpoint.
Bruyere F; Corcoran NM; Berdjis N; Namdarian B; Pedersen J; Ockrim J; Voelzke BB; Costello AJ; Hovens CM
BJU Int; 2008 Jul; 102(2):247-52. PubMed ID: 18341621
[TBL] [Abstract][Full Text] [Related]
8. Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
Sen S; Zhou H; Zhang RD; Yoon DS; Vakar-Lopez F; Ito S; Jiang F; Johnston D; Grossman HB; Ruifrok AC; Katz RL; Brinkley W; Czerniak B
J Natl Cancer Inst; 2002 Sep; 94(17):1320-9. PubMed ID: 12208897
[TBL] [Abstract][Full Text] [Related]
9. High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas.
Araki K; Nozaki K; Ueba T; Tatsuka M; Hashimoto N
J Neurooncol; 2004; 67(1-2):53-64. PubMed ID: 15072448
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.
Chen YJ; Chen CM; Twu NF; Yen MS; Lai CR; Wu HH; Wang PH; Yuan CC
Virchows Arch; 2009 Nov; 455(5):431-40. PubMed ID: 19838728
[TBL] [Abstract][Full Text] [Related]
11. Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation.
Chieffi P; Cozzolino L; Kisslinger A; Libertini S; Staibano S; Mansueto G; De Rosa G; Villacci A; Vitale M; Linardopoulos S; Portella G; Tramontano D
Prostate; 2006 Feb; 66(3):326-33. PubMed ID: 16267859
[TBL] [Abstract][Full Text] [Related]
12. Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.
Lassus H; Staff S; Leminen A; Isola J; Butzow R
Gynecol Oncol; 2011 Jan; 120(1):11-7. PubMed ID: 20937525
[TBL] [Abstract][Full Text] [Related]
13. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.
Fraizer GC; Diaz MF; Lee IL; Grossman HB; Sen S
Int J Oncol; 2004 Dec; 25(6):1631-9. PubMed ID: 15547700
[TBL] [Abstract][Full Text] [Related]
14. Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.
Nadler Y; Camp RL; Schwartz C; Rimm DL; Kluger HM; Kluger Y
Clin Cancer Res; 2008 Jul; 14(14):4455-62. PubMed ID: 18628459
[TBL] [Abstract][Full Text] [Related]
15. Expression of aurora kinases: Predictor of tumor dissemination in uterine carcinosarcoma.
Han KH; Kim MA; Park NH
Histol Histopathol; 2017 Jul; 32(7):717-724. PubMed ID: 27779297
[TBL] [Abstract][Full Text] [Related]
16. Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer.
Qi G; Ogawa I; Kudo Y; Miyauchi M; Siriwardena BS; Shimamoto F; Tatsuka M; Takata T
Virchows Arch; 2007 Mar; 450(3):297-302. PubMed ID: 17235564
[TBL] [Abstract][Full Text] [Related]
17. Aurora B kinase expression in ependymal neoplasms.
Gibson SE; Zeng WF; Weil RJ; Prayson RA
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):274-8. PubMed ID: 18301241
[TBL] [Abstract][Full Text] [Related]
18. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
19. Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy.
Nomura S; Suzuki Y; Takahashi R; Terasaki M; Kimata R; Terasaki Y; Hamasaki T; Kimura G; Shimizu A; Kondo Y
BMC Urol; 2015 Jun; 15():53. PubMed ID: 26087959
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.
Qi G; Kudo Y; Ando T; Tsunematsu T; Shimizu N; Siriwardena SB; Yoshida M; Keikhaee MR; Ogawa I; Takata T
Oral Oncol; 2010 Apr; 46(4):263-70. PubMed ID: 20138567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
